"sample.id","patient.id","event","OS","ACVR2A","ALB","APC","APOB","ARID1A","ARID1B","ARID2","ASPM","ATM","ATP10B","AXIN1","CCND1","CCNE1","CDKN2A","CTNNB1","CTNNBL1","DMD","DOCK2","DST","ERRFI1","FAT4","FGF19","FGF3","FRAS1","FZD6","GSK3B","HNF1A","HNF1B","IL6ST","IRF2","JAK1","JAK2","KEAP1","KIT","KMT2A","KMT2D","MAP1B","NAV3","NFE2L2","PEG3","PIK3CA","PTPRB","RB1","RPS6KA3","STAT3","SYNE2","TERT","TP53","TSC1","TSC2","VEGFA","WNT1","WNT5A","adjacent_hepatic_tissue_inflammation_extent_type","albumin_result_specified_value","child_pugh_classification_grade","creatinine_value_in_mg_dl","fetoprotein_outcome_value","fibrosis_ishak_score","hist_hepato_carc_fact","histological_type","neoplasm_histologic_grade","pathologic_M","pathologic_N","pathologic_T","platelet_result_count","prothrombin_time_result_value","total_bilirubin_upper_limit","vascular_tumor_cell_type","viral_hepatitis_serology","tumor_stage.diagnoses","bmi.exposures","sample_type.samples","TMB"
"TCGA-FV-A495-11A","TCGA-FV-A495",0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4,"",1,39,"3,4 - Fibrous Speta","Hepatitis C","Hepatocellular Carcinoma","G2","M0","NX","T2",258000,NA,1.9,"None","","stage ii",23.6614386155,"Solid Tissue Normal",0
"TCGA-ED-A7PZ-01A","TCGA-ED-A7PZ",0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,1,0,0,0,0,0,"Mild",4.2,"",7,2,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","NX","T2",289000,0.9,1.3,"Micro","Hepatitis B Surface Antigen","stage ii",19.777698667,"Primary Tumor",5
"TCGA-ED-A97K-01A","TCGA-ED-A97K",0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",8,"",4.6,3,"","Alcohol consumption","Hepatocholangiocarcinoma (Mixed)","G2","M0","N0","T3a",264000,0.9,1.3,"Micro","Hepatitis B Surface Antigen","stage iiia",22.1453287197,"Primary Tumor",1
"TCGA-ED-A7PX-01A","TCGA-ED-A7PX",0,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,"None",NA,"",17,24,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","NX","T2",239000,NA,1.3,"Micro","Hepatitis B Surface Antigen","stage ii",16.5888661703,"Primary Tumor",1
"TCGA-BC-A3KF-01A","TCGA-BC-A3KF",0,8,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,"",NA,"",0.8,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","NX","T1",171000,1,NA,"None","","stage i",19.3791974339,"Primary Tumor",2
"TCGA-DD-AACK-01A","TCGA-DD-AACK",0,9,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.6,"A",1.3,5,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",98000,0.9,1.2,"Micro","","stage i",22.9853975122,"Primary Tumor",3
"TCGA-DD-A4NR-01A","TCGA-DD-A4NR",1,9,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.1,"A",1,40250,"6 - Established Cirrhosis","Other","Hepatocellular Carcinoma","G3","M0","N0","T1",239000,9.3,1,"None","HBV Core Antibody","stage i",131.8359375,"Primary Tumor",1
"TCGA-RC-A6M6-01A","TCGA-RC-A6M6",0,9,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",2.8,"B",0.8,12986,"","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","NX","T2",235000,1.3,1.3,"None","","stage ii",NA,"Primary Tumor",4
"TCGA-FV-A496-11A","TCGA-FV-A496",0,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",2.8,"",1,67,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","NX","T1",167000,1,1.9,"None","","stage i",20.5761316872,"Solid Tissue Normal",0
"TCGA-DD-A3A8-01A","TCGA-DD-A3A8",1,11,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",NA,"A",0.9,4,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T2",251000,NA,1,"None","HBV Core Antibody","stage ii",31.6001149095,"Primary Tumor",1
"TCGA-DD-AADM-01A","TCGA-DD-AADM",1,12,0,0,1,0,0,1,0,0,0,0,0,0,0,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,"",4.1,"A",0.8,112,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T2",126000,1,1.2,"None","","stage ii",21.7554685337,"Primary Tumor",8
"TCGA-FV-A4ZQ-01A","TCGA-FV-A4ZQ",0,12,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",2.4,"",1,NA,"","Hepatitis C","Hepatocellular Carcinoma","G2","M0","NX","T1",NA,1.1,1.2,"None","Hepatitis C Virus RNA","stage i",NA,"Primary Tumor",5
"TCGA-DD-A11B-11A","TCGA-DD-A11B",1,14,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.9,"A",1,15,"6 - Established Cirrhosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G2","M0","N0","T1",90000,10.2,1,"None","HBV Core Antibody","stage i",40.9022923598,"Solid Tissue Normal",0
"TCGA-RC-A6M5-01A","TCGA-RC-A6M5",0,15,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.9,"A",0.4,NA,"","No History of Primary Risk Factors","Fibrolamellar Carcinoma","G2","M0","N1","T1",317000,1.2,1.3,"None","","stage iva",NA,"Primary Tumor",0
"TCGA-DD-AAC8-01A","TCGA-DD-AAC8",1,16,0,0,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.3,"A",1.1,1,"1,2 - Portal Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",177000,0.9,1.2,"Micro","","stage i",23.4220907298,"Primary Tumor",9
"TCGA-EP-A2KC-01A","TCGA-EP-A2KC",1,19,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.1,"A",NA,43,"","Hepatitis C","Hepatocellular Carcinoma","G3","MX","NX","T1",193000,1.1,NA,"None","","stage i",NA,"Primary Tumor",2
"TCGA-BW-A5NO-01A","TCGA-BW-A5NO",0,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,"",NA,"",NA,NA,"3,4 - Fibrous Speta","Hepatitis C","Hepatocellular Carcinoma","G2","MX","NX","T3a",NA,NA,NA,"None","","stage iiia",NA,"Primary Tumor",2
"TCGA-5C-AAPD-01A","TCGA-5C-AAPD",0,20,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,"None",NA,"A",NA,NA,"","Hepatitis B","Hepatocholangiocarcinoma (Mixed)","G1","M0","N0","T2",NA,NA,NA,"None","HBV Surface Antibody","stage ii",23.3234180638,"Primary Tumor",2
"TCGA-ZP-A9D1-01A","TCGA-ZP-A9D1",0,21,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,"",NA,"A",NA,8,"5 - Nodular Formation and Incomplete Cirrhosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G2","MX","NX","T1",NA,12,NA,"None","","not reported",44.9826989619,"Primary Tumor",5
"TCGA-RC-A6M4-01A","TCGA-RC-A6M4",0,22,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",2.3,"A",0.9,5,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","NX","T3",NA,NA,1.3,"None","","stage iiia",NA,"Primary Tumor",4
"TCGA-T1-A6J8-01A","TCGA-T1-A6J8",0,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","NX","T1",NA,NA,NA,"None","","not reported",18.3906745134,"Primary Tumor",2
"TCGA-G3-AAV4-01A","TCGA-G3-AAV4",1,27,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",2.7,"A",1.1,4,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G1","M0","N0","T1",79000,1.2,1.2,"None","","stage i",23.0111768573,"Primary Tumor",6
"TCGA-WQ-A9G7-01A","TCGA-WQ-A9G7",0,30,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.5,"",0.4,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","NX","T3a",266000,1.3,1.2,"None","","not reported",27.9930220293,"Primary Tumor",1
"TCGA-GJ-A6C0-01A","TCGA-GJ-A6C0",1,31,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","NX","T2",NA,NA,NA,"Micro","","stage ii",35.15625,"Primary Tumor",0
"TCGA-BC-A10Z-01A","TCGA-BC-A10Z",1,34,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.1,"",1.2,779,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","N0","T1",260000,0.9,1.2,"None","","stage i",NA,"Primary Tumor",3
"TCGA-2Y-A9HA-01A","TCGA-2Y-A9HA",1,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",3.5,"A",0.8,114,"3,4 - Fibrous Speta","Hepatitis C","Hepatocellular Carcinoma","G2","MX","NX","T2",153000,10.6,1.3,"","Hepatitis  C Antibody","stage ii",24.1588179686,"Primary Tumor",2
"TCGA-DD-A73E-01A","TCGA-DD-A73E",0,44,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.7,"A",1.2,1,"0 - No Fibrosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G1","M0","N0","T1",190000,11.5,1,"None","HBV Surface Antibody","stage i",36.5062195782,"Primary Tumor",2
"TCGA-5R-AAAM-01A","TCGA-5R-AAAM",1,46,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",3,"A",0.7,32,"6 - Established Cirrhosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T2",68000,NA,1.2,"Micro","Hepatitis B Surface Antigen","stage ii",30.1102788965,"Primary Tumor",1
"TCGA-UB-A7MD-01A","TCGA-UB-A7MD",1,52,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,"",3.5,"A",1,23,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G3","MX","N0","T1",201000,1,1.3,"Micro","Hepatitis B Surface Antigen","stage i",18.612244898,"Primary Tumor",5
"TCGA-ED-A8O6-01A","TCGA-ED-A8O6",1,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",2.8,"",2.8,3000,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T3a",NA,NA,1.3,"Micro","Hepatitis B Surface Antigen","stage iiia",16.5289256198,"Primary Tumor",2
"TCGA-G3-A7M9-01A","TCGA-G3-A7M9",1,56,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,"None",3.3,"A",1,22868,"6 - Established Cirrhosis","Hemochromatosis","Hepatocellular Carcinoma","G2","MX","NX","T3b",187000,1.1,1.4,"Macro","HBV Surface Antibody","stage iiib",25.2595155709,"Primary Tumor",3
"TCGA-KR-A7K0-01A","TCGA-KR-A7K0",1,65,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",2.8,"",0.7,11,"","Hepatitis C","Hepatocellular Carcinoma","G1","M0","N0","T1",102000,1.4,1.2,"None","Hepatitis  C Antibody","stage i",21.799445105,"Primary Tumor",3
"TCGA-G3-AAV6-01A","TCGA-G3-AAV6",1,65,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",3.9,"A",0.9,57875,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T3a",303000,1,1.2,"Micro","Hepatitis B Surface Antigen","stage iiia",28.650137741,"Primary Tumor",2
"TCGA-GJ-A9DB-01A","TCGA-GJ-A9DB",1,67,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.5,"",1.1,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","N0","T1",144000,0.9,1,"None","","stage i",27.4528868426,"Primary Tumor",1
"TCGA-DD-A11A-11A","TCGA-DD-A11A",0,79,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",NA,"",1.1,223,"0 - No Fibrosis","Other","Hepatocellular Carcinoma","G3","M0","N0","T1",513000,1,1,"None","HBV Core Antibody","stage i",27.5312294543,"Solid Tissue Normal",0
"TCGA-CC-5260-01A","TCGA-CC-5260",1,87,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","","Hepatocellular Carcinoma","G1","M0","N0","T4",NA,NA,NA,"None","Hepatitis B Surface Antigen","stage iiic",19.6505617498,"Primary Tumor",0
"TCGA-HP-A5MZ-01A","TCGA-HP-A5MZ",1,91,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",124,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","NX","T1",231000,1,NA,"None","HBV Surface Antibody","stage i",23.9590942294,"Primary Tumor",1
"TCGA-BC-A10W-11A","TCGA-BC-A10W",1,91,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",2.8,"",0.8,79,"","Hepatitis B","Hepatocellular Carcinoma","G3","MX","NX","T4",401000,0.9,1.2,"","Hepatitis B Surface Antigen","not reported",NA,"Solid Tissue Normal",0
"TCGA-QA-A7B7-01A","TCGA-QA-A7B7",0,94,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",4.2,"A",1,1751,"0 - No Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G2","MX","NX","T2",218000,11.5,1.2,"Micro","","stage ii",33.3333333333,"Primary Tumor",1
"TCGA-CC-5261-01A","TCGA-CC-5261",1,97,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","","Hepatocellular Carcinoma","G2","M0","N0","T2",NA,NA,NA,"None","Hepatitis B Surface Antigen","stage ii",18.9387755102,"Primary Tumor",0
"TCGA-CC-A1HT-01A","TCGA-CC-A1HT",1,101,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",20.3244382551,"Primary Tumor",3
"TCGA-CC-5264-01A","TCGA-CC-5264",1,102,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","","Hepatocellular Carcinoma","G2","M0","N0","T3",NA,NA,NA,"None","Hepatitis B Surface Antigen","stage iiia",20.3125,"Primary Tumor",3
"TCGA-CC-5262-01A","TCGA-CC-5262",1,103,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","M0","N0","T4",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiic",21.4532871972,"Primary Tumor",2
"TCGA-DD-AACL-01A","TCGA-DD-AACL",1,107,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,1,0,0,0,"",3.3,"A",1,1368,"","Hepatitis C","Hepatocellular Carcinoma","G3","M0","N0","T1",99000,0.9,1.2,"None","","stage i",30.6666666667,"Primary Tumor",5
"TCGA-DD-AADF-01A","TCGA-DD-AADF",1,115,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.5,"A",0.6,725,"","Hepatitis B","Hepatocellular Carcinoma","G4","M0","N0","T1",174000,1.2,1.2,"None","","stage i",26.159334126,"Primary Tumor",3
"TCGA-CC-5258-01A","TCGA-CC-5258",1,129,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","","Hepatocellular Carcinoma","G2","M0","N0","T2",NA,NA,NA,"None","HBV Surface Antibody","stage ii",NA,"Primary Tumor",2
"TCGA-CC-5263-01A","TCGA-CC-5263",1,129,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","M0","N0","T3",NA,NA,NA,"None","Hepatitis B Surface Antigen","stage iiia",22.2063306861,"Primary Tumor",1
"TCGA-DD-AAD0-01A","TCGA-DD-AAD0",0,137,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,"Mild",3.4,"A",0.5,4,"","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",86000,1,1.2,"None","","stage i",24,"Primary Tumor",3
"TCGA-CC-A8HT-01A","TCGA-CC-A8HT",1,140,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",18.9865907203,"Primary Tumor",7
"TCGA-DD-AAE6-01A","TCGA-DD-AAE6",0,141,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",4.4,"A",0.8,113,"6 - Established Cirrhosis","","Hepatocellular Carcinoma","G2","M0","N0","T1",209000,1.1,1.2,"Micro","","stage i",18.1954827736,"Primary Tumor",3
"TCGA-BC-A112-01A","TCGA-BC-A112",1,153,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.1,"",2.1,233,"0 - No Fibrosis","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","NX","T3",218000,1.1,1.2,"None","","not reported",35.6290174472,"Primary Tumor",0
"TCGA-DD-AACX-01A","TCGA-DD-AACX",0,170,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.2,"A",0.8,3,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T2",179000,0.9,1.2,"None","","stage ii",22.0603537981,"Primary Tumor",2
"TCGA-DD-AACZ-01A","TCGA-DD-AACZ",1,171,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",4.5,"A",0.6,25,"","","Hepatocellular Carcinoma","G4","M0","N0","T1",412000,1,1.2,"Macro","","stage i",23.4223683618,"Primary Tumor",3
"TCGA-DD-A39Y-01A","TCGA-DD-A39Y",1,171,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4,"A",0.8,5600,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","NX","T1",243000,10.2,1,"None","HBV Core Antibody","stage i",27.4405991736,"Primary Tumor",0
"TCGA-G3-A3CI-01A","TCGA-G3-A3CI",0,180,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",0.4,"A",0.9,2,"0 - No Fibrosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G2","M0","N0","T1",186000,1.3,0.8,"None","","stage i",35.1393022339,"Primary Tumor",1
"TCGA-DD-A1EI-01A","TCGA-DD-A1EI",0,183,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",5.1,"B",0.9,24,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",148000,10.9,1,"None","HBV DNA","stage i",22.5306122449,"Primary Tumor",1
"TCGA-FV-A3R2-01A","TCGA-FV-A3R2",1,194,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,"",NA,"",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","","MX","NX","T1",NA,NA,NA,"","HBV Surface Antibody","stage i",NA,"Primary Tumor",4
"TCGA-DD-AACH-01A","TCGA-DD-AACH",1,195,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.3,"A",1.2,7,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T2",290000,0.9,1.2,"Micro","","stage ii",20.703125,"Primary Tumor",3
"TCGA-CC-A9FS-01A","TCGA-CC-A9FS",0,211,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T2",NA,NA,NA,"","Hepatitis B Surface Antigen","stage ii",23.7812128419,"Primary Tumor",3
"TCGA-UB-A7MF-01A","TCGA-UB-A7MF",1,214,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",3.6,"A",0.9,2505,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G2","MX","NX","T3a",130000,1,1.3,"Micro","HBV DNA","stage iiia",24.9835634451,"Primary Tumor",2
"TCGA-CC-A7IE-01A","TCGA-CC-A7IE",1,217,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",20.9572742023,"Primary Tumor",1
"TCGA-CC-A123-01A","TCGA-CC-A123",0,219,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","","Hepatocellular Carcinoma","G1","M0","N0","T3",NA,NA,NA,"None","Hepatitis B Surface Antigen","stage iiia",NA,"Primary Tumor",3
"TCGA-DD-A119-11A","TCGA-DD-A119",1,223,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.9,"A",1.3,1836,"0 - No Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G3","M1","N0","T3a",572000,1,1,"Micro","HBV Core Antibody","stage iv",22.65625,"Solid Tissue Normal",0
"TCGA-MR-A520-01A","TCGA-MR-A520",0,229,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Other","Hepatocellular Carcinoma","G1","MX","NX","T1",NA,NA,NA,"","HBV Core Antibody","stage i",32.4584126588,"Primary Tumor",0
"TCGA-DD-A3A1-01A","TCGA-DD-A3A1",1,233,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.8,"A",1.1,6,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T3b",178000,11.2,1.1,"Macro","","stage iiia",22.7903579255,"Primary Tumor",0
"TCGA-FV-A3I1-11A","TCGA-FV-A3I1",1,247,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"0 - No Fibrosis","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","N0","T2",NA,NA,NA,"Micro","HBV Surface Antibody","stage ii",NA,"Solid Tissue Normal",0
"TCGA-CC-A9FW-01A","TCGA-CC-A9FW",0,248,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",21.8775510204,"Primary Tumor",4
"TCGA-CC-5259-01A","TCGA-CC-5259",0,250,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T4",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiic",20.9321201247,"Primary Tumor",3
"TCGA-2Y-A9HB-01A","TCGA-2Y-A9HB",0,260,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,"None",3.9,"",0.8,21,"","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","NX","T1",124000,11.1,1.3,"None","HCV Genotype","stage i",26.5337588296,"Primary Tumor",3
"TCGA-4R-AA8I-01A","TCGA-4R-AA8I",1,262,1,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,1,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,"None",3.8,"A",0.7,5,"6 - Established Cirrhosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G2","MX","NX","T2",96000,1.1,1.5,"Micro","Hepatitis B Surface Antigen","stage ii",35.2245135255,"Primary Tumor",12
"TCGA-CC-A7IK-01A","TCGA-CC-A7IK",1,262,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",20.1955782313,"Primary Tumor",6
"TCGA-CC-A5UE-01A","TCGA-CC-A5UE",1,272,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T4",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiib",21.2244897959,"Primary Tumor",4
"TCGA-CC-A7IL-01A","TCGA-CC-A7IL",1,278,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G1","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",20.8085612366,"Primary Tumor",2
"TCGA-CC-A8HV-01A","TCGA-CC-A8HV",1,279,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T2",NA,NA,NA,"","Hepatitis B Surface Antigen","stage ii",20.1732526403,"Primary Tumor",1
"TCGA-DD-A73B-01A","TCGA-DD-A73B",1,283,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.5,"B",0.9,30,"6 - Established Cirrhosis","Other","Hepatocellular Carcinoma","G2","M0","N0","T1",88000,1.1,1,"None","Hepatitis B Surface Antigen","stage i",31.2025636701,"Primary Tumor",1
"TCGA-MI-A75C-01A","TCGA-MI-A75C",0,291,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"",4,"A",1,4,"","Hepatitis C","Hepatocellular Carcinoma","G3","M0","N0","T1",243000,NA,1.2,"None","HBV Surface Antibody","stage i",27.4285714286,"Primary Tumor",3
"TCGA-ED-A66Y-01A","TCGA-ED-A66Y",1,296,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,"Mild",6,"",4.4,12100,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T3a",289000,0.9,1.3,"Micro","Hepatitis B Surface Antigen","stage iiia",23.046875,"Primary Tumor",5
"TCGA-CC-A7IG-01A","TCGA-CC-A7IG",1,299,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T2",NA,NA,NA,"","Hepatitis B Surface Antigen","stage ii",20.4782666138,"Primary Tumor",3
"TCGA-CC-A8HS-01A","TCGA-CC-A8HS",1,300,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","M0","N1","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiic",20.9572742023,"Primary Tumor",1
"TCGA-CC-A3M9-01A","TCGA-CC-A3M9",1,300,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",20.147971991,"Primary Tumor",3
"TCGA-EP-A3JL-01A","TCGA-EP-A3JL",0,303,0,1,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.1,"A",NA,13,"","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","NX","T1",149000,NA,1.2,"None","","stage i",25.8645124717,"Primary Tumor",5
"TCGA-CC-A3MA-01A","TCGA-CC-A3MA",1,303,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",23.3843537415,"Primary Tumor",2
"TCGA-CC-A5UD-01A","TCGA-CC-A5UD",1,304,0,0,0,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",21.4532871972,"Primary Tumor",6
"TCGA-BC-A10R-01A","TCGA-BC-A10R",1,308,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",4,"",0.7,27,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","NX","T3",209000,0.9,NA,"Micro","","not reported",NA,"Primary Tumor",2
"TCGA-UB-AA0V-01A","TCGA-UB-AA0V",0,314,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.8,"A",0.7,3,"0 - No Fibrosis","Hemochromatosis","Hepatocellular Carcinoma","G1","MX","NX","",273000,0.9,1.3,"None","HBV Core Antibody","stage i",18.612244898,"Primary Tumor",0
"TCGA-CC-A3MB-01A","TCGA-CC-A3MB",1,315,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",18.7241735537,"Primary Tumor",3
"TCGA-5C-A9VH-01A","TCGA-5C-A9VH",0,322,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",NA,"A",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T1",NA,NA,NA,"None","","stage i",25.3443526171,"Primary Tumor",0
"TCGA-UB-AA0U-01A","TCGA-UB-AA0U",0,327,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.9,"A",0.6,26,"0 - No Fibrosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G2","MX","NX","T2",227000,1.1,1.3,"None","HBV Core Antibody","stage ii",29.3523545007,"Primary Tumor",2
"TCGA-5C-A9VG-01A","TCGA-5C-A9VG",0,328,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",NA,"A",NA,NA,"","Other","Hepatocellular Carcinoma","G2","M0","N0","T2",NA,NA,NA,"Micro","","stage ii",25.2595155709,"Primary Tumor",1
"TCGA-MR-A8JO-01A","TCGA-MR-A8JO",0,330,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.1,"",NA,2,"","Alcohol consumption","Fibrolamellar Carcinoma","G3","MX","N0","T1",162000,NA,1.3,"None","HBV Core Antibody","stage i",23.4277384423,"Primary Tumor",0
"TCGA-ZS-A9CG-01A","TCGA-ZS-A9CG",0,341,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",40,"A",72,NA,"0 - No Fibrosis","","Hepatocellular Carcinoma","G2","MX","NX","T2",382000,10.8,21,"Micro","Hepatitis B Surface Antigen","stage ii",29.3374114416,"Primary Tumor",1
"TCGA-CC-A8HU-01A","TCGA-CC-A8HU",1,344,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",15.8078964206,"Primary Tumor",3
"TCGA-WJ-A86L-01A","TCGA-WJ-A86L",0,345,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",4.2,"A",0.9,16,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","NX","T1",257000,0.9,1.2,"None","HBV Surface Antibody","stage i",22.151022507,"Primary Tumor",4
"TCGA-CC-A5UC-01A","TCGA-CC-A5UC",1,347,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",20.9366391185,"Primary Tumor",2
"TCGA-DD-AAC9-01A","TCGA-DD-AAC9",0,347,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.2,"A",1.3,5,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",149000,0.9,1.2,"None","","stage i",26.7538644471,"Primary Tumor",1
"TCGA-DD-A1EE-11A","TCGA-DD-A1EE",1,349,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",2.7,"B",1.2,3,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G3","M0","N0","T3",208000,14.3,1,"None","HBV Core Antibody","stage iiia",25.1428571429,"Solid Tissue Normal",0
"TCGA-G3-AAV5-01A","TCGA-G3-AAV5",0,354,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.2,"A",0.8,NA,"6 - Established Cirrhosis","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T2",326000,1,1.4,"Macro","HBV Core Antibody","stage ii",32.3232323232,"Primary Tumor",2
"TCGA-2Y-A9H6-01A","TCGA-2Y-A9H6",0,357,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4,"",1.8,114,"","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","NX","T1",224000,10.5,1.3,"Macro","","stage i",40.6804733728,"Primary Tumor",0
"TCGA-K7-AAU7-01A","TCGA-K7-AAU7",0,359,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"A",NA,290,"","Hemochromatosis","Hepatocholangiocarcinoma (Mixed)","G2","MX","NX","T2a",87000,0.9,NA,"Micro","","stage ii",NA,"Primary Tumor",4
"TCGA-G3-AAV1-01A","TCGA-G3-AAV1",1,359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",3.2,"B",0.7,8,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T4",115000,1.2,1.4,"Micro","HBV DNA","stage iiic",30.2188577882,"Primary Tumor",1
"TCGA-G3-AAV7-01A","TCGA-G3-AAV7",0,361,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,"Mild",4,"A",1.1,3,"5 - Nodular Formation and Incomplete Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T2",179000,1,1.4,"Micro","HBV DNA","stage ii",21.3039485767,"Primary Tumor",5
"TCGA-G3-A7M7-01A","TCGA-G3-A7M7",0,361,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",3.5,"A",0.6,4,"3,4 - Fibrous Speta","Alcohol consumption","Hepatocellular Carcinoma","G1","MX","NX","T1",145000,1.1,1.2,"None","Hepatitis B Surface Antigen","stage i",23.5035560575,"Primary Tumor",0
"TCGA-EP-A3RK-01A","TCGA-EP-A3RK",0,363,1,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.3,"A",NA,7,"1,2 - Portal Fibrosis","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","NX","T3a",234000,1.1,1.2,"","","stage iiia",31.8772882212,"Primary Tumor",3
"TCGA-CC-A3MC-01A","TCGA-CC-A3MC",0,363,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",19.5716812827,"Primary Tumor",0
"TCGA-CC-A7IH-01A","TCGA-CC-A7IH",0,365,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G1","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",18.2857142857,"Primary Tumor",9
"TCGA-DD-AACF-01A","TCGA-DD-AACF",1,365,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",3.5,"A",1.1,16,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G3","M0","N0","T1",99000,1.1,1.2,"None","","stage i",21.2585034014,"Primary Tumor",2
"TCGA-LG-A9QD-01A","TCGA-LG-A9QD",0,366,0,1,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",2.9,"",0.9,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T3a",320000,NA,1.2,"None","","stage iiia",26.2188208617,"Primary Tumor",4
"TCGA-FV-A3R3-01A","TCGA-FV-A3R3",1,366,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",2,"",1.3,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","NX","T1",323000,10.7,1,"None","","stage i",37.4213957795,"Primary Tumor",0
"TCGA-G3-AAV2-01A","TCGA-G3-AAV2",0,372,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.2,"A",1,4,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G1","M0","N0","T1",110000,1,1.4,"None","HBV Surface Antibody","stage i",NA,"Primary Tumor",1
"TCGA-DD-A4NQ-01A","TCGA-DD-A4NQ",1,373,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,"Mild",4.4,"A",0.8,141,"","Other","Hepatocellular Carcinoma","G3","M0","N0","T2",283000,10.1,1,"Macro","HBV Core Antibody","stage ii",29.6665480005,"Primary Tumor",2
"TCGA-DD-AACD-01A","TCGA-DD-AACD",1,381,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.9,"A",1,2,"1,2 - Portal Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G4","M0","N0","T1",268000,6.9,1.2,"Micro","","stage i",19.9251298152,"Primary Tumor",3
"TCGA-CC-A7IJ-01A","TCGA-CC-A7IJ",0,382,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","N0","T2",NA,NA,NA,"","Hepatitis B Surface Antigen","stage ii",19.8347107438,"Primary Tumor",4
"TCGA-BC-A69I-01A","TCGA-BC-A69I",0,387,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",NA,"",1.2,2,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","M0","N0","T1",171000,10.4,1.2,"None","","stage i",29.3209876543,"Primary Tumor",0
"TCGA-LG-A6GG-11A","TCGA-LG-A6GG",0,387,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.7,"A",0.6,NA,"","Other","Hepatocellular Carcinoma","G2","M0","NX","T2",93000,12.2,1,"Micro","","stage ii",26.0374939913,"Solid Tissue Normal",0
"TCGA-ED-A7PY-01A","TCGA-ED-A7PY",0,390,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",NA,"",3.9,2,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","NX","T2",282000,0.9,1.3,"Micro","Hepatitis B Surface Antigen","stage ii",16.4365548981,"Primary Tumor",3
"TCGA-DD-A1EF-11A","TCGA-DD-A1EF",1,394,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.5,"B",0.9,16211,"3,4 - Fibrous Speta","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T1",337000,8.5,1,"None","HBV Core Antibody","stage i",30.1160023795,"Solid Tissue Normal",0
"TCGA-ZP-A9D4-01A","TCGA-ZP-A9D4",0,395,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.3,"A",0.6,2,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","MX","NX","T1",292000,NA,1.2,"None","","not reported",22.8928199792,"Primary Tumor",3
"TCGA-WQ-AB4B-01A","TCGA-WQ-AB4B",0,395,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",3.3,"A",1.1,5,"","Other","Hepatocellular Carcinoma","G2","M0","NX","T2",NA,1.3,1.2,"Micro","","stage ii",39.8367346939,"Primary Tumor",2
"TCGA-3K-AAZ8-01A","TCGA-3K-AAZ8",0,396,0,1,0,0,0,1,1,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"5 - Nodular Formation and Incomplete Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G1","MX","NX","T3b",NA,NA,NA,"","","stage iiib",28.3937263386,"Primary Tumor",6
"TCGA-CC-A7II-01A","TCGA-CC-A7II",0,399,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",18.4240362812,"Primary Tumor",5
"TCGA-ED-A7XP-01A","TCGA-ED-A7XP",0,400,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,1,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",6.9,"",4.8,18,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T2",108000,1,1.3,"Micro","Hepatitis B Surface Antigen","stage ii",21.9075824577,"Primary Tumor",7
"TCGA-ED-A66X-01A","TCGA-ED-A66X",0,406,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.7,"",4.5,5840,"","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","N0","T3a",268000,1,1.3,"Micro","Hepatitis B Surface Antigen","stage iiia",21.107266436,"Primary Tumor",0
"TCGA-ED-A8O5-01A","TCGA-ED-A8O5",0,406,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,"Mild",4.2,"",3.4,498,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T3a",171000,1.3,1.3,"Micro","Hepatitis B Surface Antigen","stage iiia",23.1404958678,"Primary Tumor",5
"TCGA-ED-A82E-01A","TCGA-ED-A82E",0,408,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.3,"",2.8,4,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T3a",261000,0.9,1.3,"Micro","Hepatitis B Surface Antigen","stage iiia",19.5555555556,"Primary Tumor",0
"TCGA-BD-A3EP-01A","TCGA-BD-A3EP",0,409,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",3.8,"A",1.1,17,"1,2 - Portal Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T1",333000,1,1.5,"None","","stage i",25.1558956916,"Primary Tumor",4
"TCGA-DD-AA3A-01A","TCGA-DD-AA3A",1,410,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.9,"A",0.7,1,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocholangiocarcinoma (Mixed)","G4","MX","N0","T1",256000,1.1,1,"None","HBV Core Antibody","stage i",26.314635323,"Primary Tumor",0
"TCGA-YA-A8S7-01A","TCGA-YA-A8S7",1,412,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",2.1,"",0.7,56,"","Hepatitis C","Hepatocellular Carcinoma","G3","MX","N0","T3a",NA,1.2,1,"None","","stage iiia",27.1415823914,"Primary Tumor",2
"TCGA-G3-AAV3-01A","TCGA-G3-AAV3",0,412,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",4.4,"A",0.6,5,"6 - Established Cirrhosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G2","M0","N0","T2",113000,1.1,1.4,"None","","stage ii",30.1162131519,"Primary Tumor",2
"TCGA-DD-A1EL-11A","TCGA-DD-A1EL",1,415,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.4,"A",1,5,"0 - No Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T2",153000,10.8,1,"None","HBV DNA","stage ii",16.3023789397,"Solid Tissue Normal",0
"TCGA-DD-AACP-01A","TCGA-DD-AACP",0,415,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,"None",4.1,"A",1.1,227,"","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","N0","T1",151000,0.9,1.2,"None","","stage i",25.8064516129,"Primary Tumor",3
"TCGA-G3-A25S-01A","TCGA-G3-A25S",1,416,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",0.4,"A",1,281,"6 - Established Cirrhosis","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T1",313000,1,1.4,"Micro","","stage i",26.4915082015,"Primary Tumor",0
"TCGA-DD-A3A7-11A","TCGA-DD-A3A7",1,419,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",NA,"",1.4,120,"0 - No Fibrosis","Other","Hepatocellular Carcinoma","G3","M0","N0","T3b",562000,10.6,1.1,"Micro","HBV Core Antibody","stage iiib",22.6346763241,"Solid Tissue Normal",0
"TCGA-ED-A627-01A","TCGA-ED-A627",0,423,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","NX","T1",NA,NA,NA,"","Hepatitis B Surface Antigen","stage i",23.8894628099,"Primary Tumor",1
"TCGA-LG-A9QC-01A","TCGA-LG-A9QC",0,425,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.7,"",0.8,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","NX","T1",275000,12.1,1,"Micro","","stage i",29.1421457673,"Primary Tumor",1
"TCGA-DD-AADC-01A","TCGA-DD-AADC",1,425,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",3.8,"A",0.8,36,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",212000,1.2,1.2,"Macro","","stage i",26.1492768595,"Primary Tumor",3
"TCGA-ED-A7XO-01A","TCGA-ED-A7XO",0,427,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",4.2,"",4.9,4,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T3a",NA,NA,1.3,"Micro","Hepatitis B Surface Antigen","stage iiia",20.8979591837,"Primary Tumor",2
"TCGA-G3-A7M8-01A","TCGA-G3-A7M8",0,430,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"",3.5,"A",0.7,5,"6 - Established Cirrhosis","Alcohol consumption","Hepatocellular Carcinoma","G1","MX","NX","T1",136000,1.1,1.2,"None","HBV Surface Antibody","stage i",NA,"Primary Tumor",2
"TCGA-DD-AACQ-01A","TCGA-DD-AACQ",1,432,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",4.2,"A",1.3,7,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T2",157000,1,1.2,"None","","stage ii",22.4081789853,"Primary Tumor",3
"TCGA-DD-AADQ-01A","TCGA-DD-AADQ",0,436,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.4,"A",0.7,7,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T2",163000,1.1,1.2,"None","","stage ii",23.507805326,"Primary Tumor",3
"TCGA-ES-A2HT-11A","TCGA-ES-A2HT",1,438,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.1,"A",0.7,4,"0 - No Fibrosis","Hepatitis C","Hepatocellular Carcinoma","G2","MX","NX","T1",135000,1.1,1,"None","","stage i",26.4235698243,"Solid Tissue Normal",0
"TCGA-BC-A69H-01A","TCGA-BC-A69H",0,444,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",4.3,"A",0.8,103900,"","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","NX","T2",194000,10.7,1.2,"Micro","","stage ii",23.3886865582,"Primary Tumor",2
"TCGA-G3-A7M5-01A","TCGA-G3-A7M5",0,447,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.1,"A",1.9,6,"0 - No Fibrosis","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","NX","T1",181000,0.9,1.4,"None","HBV Surface Antibody","stage i",25.2825698989,"Primary Tumor",2
"TCGA-5R-AA1D-01A","TCGA-5R-AA1D",0,449,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.3,"B",0.7,5,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T3a",333000,19,1.2,"Micro","Hepatitis B Surface Antigen","stage iiia",22.761467536,"Primary Tumor",0
"TCGA-G3-A25Y-01A","TCGA-G3-A25Y",1,452,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,"Mild",0.4,"A",0.6,35,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",166000,1.1,1.2,"None","","stage i",22.8328793463,"Primary Tumor",1
"TCGA-DD-AADO-01A","TCGA-DD-AADO",0,453,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.5,"A",0.6,176037,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",180000,1,1.2,"Micro","","stage i",20.5498866213,"Primary Tumor",4
"TCGA-DD-AADP-01A","TCGA-DD-AADP",0,458,0,0,0,0,1,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.7,"A",0.5,9,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",102000,1.1,1.2,"Micro","","stage i",24.0238086701,"Primary Tumor",3
"TCGA-RC-A7SH-01A","TCGA-RC-A7SH",0,468,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",4.1,"A",0.8,2466,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T2",225000,1,1.3,"Micro","","stage ii",22.4600343506,"Primary Tumor",2
"TCGA-DD-AACG-01A","TCGA-DD-AACG",1,469,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",3.6,"A",1.5,11718,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G4","M0","N0","T2",196000,0.9,1.2,"Micro","","stage ii",23.0300453515,"Primary Tumor",3
"TCGA-RC-A7SK-01A","TCGA-RC-A7SK",0,472,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",4.3,"A",1,25,"1,2 - Portal Fibrosis","Hepatitis C","Hepatocellular Carcinoma","G3","M0","N0","T1",138000,1,1.3,"Micro","","stage i",21.0076677987,"Primary Tumor",3
"TCGA-DD-AADS-01A","TCGA-DD-AADS",0,474,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,"",3.7,"A",0.9,11,"","Hepatitis C","Hepatocellular Carcinoma","G2","M0","N0","T1",120000,1.2,1.2,"None","","stage i",19.7055324212,"Primary Tumor",2
"TCGA-G3-AAV0-01A","TCGA-G3-AAV0",0,476,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.2,"A",0.9,4,"0 - No Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",193000,0.9,1.4,"None","HBV Surface Antibody","stage i",23.2334561769,"Primary Tumor",5
"TCGA-DD-AAEB-01A","TCGA-DD-AAEB",0,478,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,"",4.1,"A",0.6,1,"","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",270000,1,1.2,"None","","stage i",28.9340689017,"Primary Tumor",3
"TCGA-G3-AAUZ-01A","TCGA-G3-AAUZ",0,480,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",3.8,"A",0.8,3,"1,2 - Portal Fibrosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G2","M0","N0","T1",214000,1,1.4,"None","HBV DNA","stage i",30.078125,"Primary Tumor",1
"TCGA-UB-A7ME-01A","TCGA-UB-A7ME",0,486,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.2,"B",1.1,1388,"1,2 - Portal Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G2","MX","NX","T1",181000,1,1.3,"None","HBV DNA","stage i",27.5482093664,"Primary Tumor",1
"TCGA-UB-A7MC-01A","TCGA-UB-A7MC",0,500,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",3.9,"A",0.7,126,"1,2 - Portal Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G3","MX","N0","T3a",2e+05,0.9,1.3,"Micro","HBV DNA","stage iiia",25.180785124,"Primary Tumor",3
"TCGA-MI-A75E-01A","TCGA-MI-A75E",0,507,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,"",3,"A",NA,5,"1,2 - Portal Fibrosis","Hepatitis C","Hepatocellular Carcinoma","G2","M0","N0","T4",158000,NA,1.2,"Micro","HCV Genotype","stage iiic",33.6326530612,"Primary Tumor",4
"TCGA-K7-A6G5-01A","TCGA-K7-A6G5",0,512,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Hemochromatosis","Hepatocellular Carcinoma","G2","MX","N0","T1",NA,NA,NA,"None","HCV Genotype","stage i",23.629489603,"Primary Tumor",2
"TCGA-K7-A5RG-01A","TCGA-K7-A5RG",0,519,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,"",NA,"",NA,19,"","Hepatitis C","Hepatocellular Carcinoma","G1","MX","NX","T1",NA,NA,NA,"None","HCV Genotype","stage i",41.0972635237,"Primary Tumor",4
"TCGA-5R-AA1C-01A","TCGA-5R-AA1C",0,520,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3,"B",1,2,"1,2 - Portal Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T2",223000,18,1.2,"Micro","Hepatitis B Surface Antigen","stage ii",29.7265160523,"Primary Tumor",4
"TCGA-G3-A5SM-01A","TCGA-G3-A5SM",0,520,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",3.2,"A",0.5,12,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G3","M0","NX","T2",260000,0.9,1.4,"None","","stage ii",31.309073724,"Primary Tumor",1
"TCGA-DD-A3A3-01A","TCGA-DD-A3A3",1,535,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,"None",NA,"B",1.2,6,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T1",276000,8.8,1.1,"Macro","","stage i",25.4580659041,"Primary Tumor",1
"TCGA-O8-A75V-01A","TCGA-O8-A75V",0,538,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.8,"A",1,7,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G2","MX","NX","T1",211000,9.1,1.2,"None","","stage i",28.3950617284,"Primary Tumor",1
"TCGA-BC-A5W4-01A","TCGA-BC-A5W4",1,547,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",4.2,"A",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","NX","T3a",102000,12.9,1.2,"Micro","","stage iiia",31.6521842993,"Primary Tumor",2
"TCGA-DD-AAE1-01A","TCGA-DD-AAE1",0,552,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.1,"A",0.8,2693,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",102000,0.9,1.2,"None","","stage i",21.707923392,"Primary Tumor",1
"TCGA-DD-AADU-01A","TCGA-DD-AADU",0,554,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.3,"A",0.8,52,"3,4 - Fibrous Speta","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","N0","T2",223000,1,1.2,"Micro","","stage ii",26.4915082015,"Primary Tumor",3
"TCGA-2Y-A9H5-01A","TCGA-2Y-A9H5",1,555,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.9,"",0.6,11700,"1,2 - Portal Fibrosis","Hepatitis C","Hepatocellular Carcinoma","G3","MX","N0","T1",204000,10.2,1.3,"None","HCV Genotype","stage i",27.9930220293,"Primary Tumor",2
"TCGA-DD-AADY-01A","TCGA-DD-AADY",0,555,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,"None",3.5,"A",0.6,9,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",159000,1.3,1.2,"None","","stage i",21.2183171946,"Primary Tumor",1
"TCGA-DD-AAE0-01A","TCGA-DD-AAE0",0,555,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",4.8,"A",0.5,8751,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G4","M0","N0","T3a",226000,0.9,1.2,"None","","stage iiia",22.151022507,"Primary Tumor",1
"TCGA-WX-AA47-01A","TCGA-WX-AA47",1,556,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",2.8,"A",0.6,1,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","NX","T3a",423000,0.9,1.2,"Macro","Hepatitis  C Antibody","stage iiia",22.3214285714,"Primary Tumor",2
"TCGA-DD-A1EK-01A","TCGA-DD-A1EK",1,558,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,"Mild",4.3,"A",0.7,19,"0 - No Fibrosis","Other","Hepatocellular Carcinoma","G2","M1","N0","T4",387000,10.3,1,"None","HBV Core Antibody","stage ivb",38.3687354139,"Primary Tumor",2
"TCGA-BC-A8YO-01A","TCGA-BC-A8YO",0,562,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",4.3,"",0.8,NA,"","Other","Hepatocellular Carcinoma","G3","M0","N0","T4",441000,1,1.2,"Macro","","stage iiic",25.6055363322,"Primary Tumor",2
"TCGA-DD-AAD1-01A","TCGA-DD-AAD1",0,564,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,"",4.5,"A",0.5,451,"","Hepatitis C","Hepatocellular Carcinoma","G4","M0","N0","T1",157000,0.9,1.2,"None","","stage i",16.9746537556,"Primary Tumor",3
"TCGA-DD-AAE3-01A","TCGA-DD-AAE3",0,566,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.7,"A",0.8,2,"1,2 - Portal Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",180000,1.1,1.2,"None","","stage i",26.81359045,"Primary Tumor",3
"TCGA-EP-A12J-01A","TCGA-EP-A12J",0,570,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.2,"B",0.8,NA,"","Hepatitis C","Hepatocellular Carcinoma","G1","MX","NX","T1",187000,1.1,1,"None","","stage i",NA,"Primary Tumor",3
"TCGA-DD-AADV-01A","TCGA-DD-AADV",0,574,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",3.8,"A",0.9,11,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",187000,1,1.2,"None","","stage i",20.6611570248,"Primary Tumor",2
"TCGA-DD-AAEA-01A","TCGA-DD-AAEA",0,575,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",4.5,"A",0.9,2,"1,2 - Portal Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",255000,1,1.2,"None","","stage i",24.8409800896,"Primary Tumor",2
"TCGA-RC-A7SF-01A","TCGA-RC-A7SF",0,579,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.4,"A",1,87,"3,4 - Fibrous Speta","Hepatitis C","Hepatocellular Carcinoma","G2","M0","N0","T1",209000,0.9,1.3,"None","","stage i",26.2975778547,"Primary Tumor",0
"TCGA-FV-A2QR-01A","TCGA-FV-A2QR",1,581,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Other","Hepatocellular Carcinoma","G1","M0","N0","T1",NA,NA,NA,"","","stage i",NA,"Primary Tumor",1
"TCGA-G3-A3CK-01A","TCGA-G3-A3CK",0,585,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",0.2,"A",1.1,3,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",143000,1,1.4,"None","","stage i",23.1833910035,"Primary Tumor",2
"TCGA-DD-AADW-01A","TCGA-DD-AADW",0,587,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,"None",4.3,"A",0.8,250,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",102000,1,1.2,"None","","stage i",18.4425458241,"Primary Tumor",2
"TCGA-RC-A7SB-01A","TCGA-RC-A7SB",0,588,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",4.8,"B",1.1,3,"0 - No Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T2",196000,1,1.3,"None","","stage ii",22.13673973,"Primary Tumor",3
"TCGA-G3-A3CJ-01A","TCGA-G3-A3CJ",0,594,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",0.4,"A",0.8,3,"5 - Nodular Formation and Incomplete Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G2","M0","N0","T2",185000,1,1.4,"Micro","","stage ii",23.7812128419,"Primary Tumor",0
"TCGA-EP-A2KB-01A","TCGA-EP-A2KB",1,596,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,"",3.8,"A",NA,2128,"","Hepatitis C","Hepatocellular Carcinoma","G2","MX","NX","T1",133000,1.4,1,"None","","stage i",29.7520661157,"Primary Tumor",3
"TCGA-DD-A39Z-01A","TCGA-DD-A39Z",1,601,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,"",3.1,"B",0.7,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","NX","T2",437000,12.6,1.1,"None","","stage ii",22.4058769513,"Primary Tumor",3
"TCGA-UB-A7MB-01A","TCGA-UB-A7MB",0,601,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,1,1,0,0,0,0,1,1,0,0,0,0,"None",3.1,"A",0.4,1865,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","MX","NX","T2",583000,1,1.3,"Micro","HBV Core Antibody","stage ii",19.1358024691,"Primary Tumor",12
"TCGA-DD-A1EC-01A","TCGA-DD-A1EC",0,602,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.2,"A",0.8,2,"0 - No Fibrosis","","Hepatocellular Carcinoma","G3","M0","N0","T1",556000,11,1,"None","","stage i",20.284798572,"Primary Tumor",0
"TCGA-DD-AAE4-01A","TCGA-DD-AAE4",0,608,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4,"A",0.5,7,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G1","M0","N0","T1",113000,1.1,1.2,"None","","stage i",25.1531502292,"Primary Tumor",1
"TCGA-EP-A26S-01A","TCGA-EP-A26S",0,608,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.5,"",NA,NA,"0 - No Fibrosis","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","N0","T1",234000,12.9,1,"None","","stage i",14.5266439909,"Primary Tumor",2
"TCGA-DD-A3A4-11A","TCGA-DD-A3A4",1,612,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.3,"B",1,NA,"0 - No Fibrosis","Other","Hepatocellular Carcinoma","G3","M0","N0","T3",283000,11,1,"None","","stage iiia",18.1965790431,"Solid Tissue Normal",0
"TCGA-WX-AA44-01A","TCGA-WX-AA44",0,615,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,1,0,0,0,0,0,"None",4.4,"A",0.6,48,"6 - Established Cirrhosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G3","MX","NX","T1",215000,0.9,1.2,"None","Hepatitis  C Antibody","stage i",26.4023545706,"Primary Tumor",3
"TCGA-G3-A5SL-01A","TCGA-G3-A5SL",0,621,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.2,"",1,4,"0 - No Fibrosis","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","NX","T2",295000,1,1.4,"Micro","","stage ii",27.1604938272,"Primary Tumor",2
"TCGA-EP-A2KA-01A","TCGA-EP-A2KA",1,627,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,"",NA,"",0.7,13,"1,2 - Portal Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","MX","NX","T3a",435000,NA,NA,"","","stage iiia",NA,"Primary Tumor",3
"TCGA-MI-A75I-01A","TCGA-MI-A75I",0,630,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,"",NA,"A",NA,NA,"","Hepatitis C","Hepatocellular Carcinoma","G1","MX","NX","T2",153000,NA,NA,"","","not reported",28.2933454052,"Primary Tumor",2
"TCGA-K7-A5RF-01A","TCGA-K7-A5RF",0,631,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,5,"","Hepatitis C","Hepatocellular Carcinoma","G1","MX","NX","T1",NA,NA,NA,"","Hepatitis C Virus RNA","stage i",23.9394809921,"Primary Tumor",0
"TCGA-G3-A7M6-01A","TCGA-G3-A7M6",0,632,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",3.6,"A",0.6,24,"1,2 - Portal Fibrosis","Hepatitis C","Hepatocellular Carcinoma","G3","MX","NX","T1",273000,0.9,1.2,"None","","stage i",30.844415959,"Primary Tumor",2
"TCGA-2Y-A9H8-01A","TCGA-2Y-A9H8",1,633,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",4.2,"",0.6,234000,"","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","NX","T1",255000,10.3,1.3,"","HBV DNA","not reported",17.7777777778,"Primary Tumor",1
"TCGA-DD-AADL-01A","TCGA-DD-AADL",0,636,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,"",3.5,"A",0.5,14,"","Hepatitis B","Hepatocellular Carcinoma","G4","M0","N0","T1",204000,0.9,1.2,"Micro","","stage i",20.964360587,"Primary Tumor",2
"TCGA-DD-AAE2-01A","TCGA-DD-AAE2",0,638,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.4,"A",0.8,41,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",238000,1,1.2,"None","","stage i",27.0841590699,"Primary Tumor",0
"TCGA-PD-A5DF-01A","TCGA-PD-A5DF",1,639,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T4",NA,NA,NA,"","","stage iiib",25.8166302126,"Primary Tumor",0
"TCGA-RC-A7S9-01A","TCGA-RC-A7S9",0,640,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,"Mild",4.3,"A",0.7,10,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",178000,1.1,1.3,"None","","stage i",22.3756799506,"Primary Tumor",2
"TCGA-DD-A39V-11A","TCGA-DD-A39V",1,643,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4,"A",0.9,NA,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","NX","T2",193000,11.4,NA,"None","","stage ii",26.0932752015,"Solid Tissue Normal",0
"TCGA-DD-AAE7-01A","TCGA-DD-AAE7",0,644,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"Severe",4.7,"A",0.9,1,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",188000,1,1.2,"None","","stage i",25.0135208221,"Primary Tumor",7
"TCGA-CC-A7IF-01A","TCGA-CC-A7IF",1,649,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G1","M0","N0","T3",NA,NA,NA,"","Hepatitis B Surface Antigen","stage iiia",20.3074122055,"Primary Tumor",1
"TCGA-G3-A25Z-01A","TCGA-G3-A25Z",0,655,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",0.4,"A",1.1,44,"5 - Nodular Formation and Incomplete Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",115000,1,1.4,"None","","stage i",23.0545624645,"Primary Tumor",2
"TCGA-DD-AAD2-01A","TCGA-DD-AAD2",0,658,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.5,"A",0.8,25,"1,2 - Portal Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",172000,1,1.2,"Micro","","stage i",21.3675213675,"Primary Tumor",4
"TCGA-DD-A4NE-11A","TCGA-DD-A4NE",1,660,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.2,"A",0.8,28,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T3a",348000,10.2,1,"None","HBV Core Antibody","stage iiia",27.3356401384,"Solid Tissue Normal",0
"TCGA-DD-A11C-11A","TCGA-DD-A11C",0,662,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.6,"A",0.9,11,"0 - No Fibrosis","","Hepatocellular Carcinoma","G3","M0","N0","T1",391000,1,1,"None","HBV Core Antibody","stage i",35.5532431495,"Solid Tissue Normal",0
"TCGA-DD-AAE8-01A","TCGA-DD-AAE8",0,664,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",4.3,"A",0.6,3,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",125000,1.1,1.2,"None","","stage i",26.9896193772,"Primary Tumor",2
"TCGA-G3-A6UC-01A","TCGA-G3-A6UC",0,671,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.6,"A",0.9,4,"6 - Established Cirrhosis","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T3b",257000,1.1,1.4,"Micro","HBV Surface Antibody","stage iiib",27.4725274725,"Primary Tumor",2
"TCGA-DD-AAD6-01A","TCGA-DD-AAD6",0,672,0,1,0,0,0,0,0,0,0,0,0,0,0,1,1,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",2.7,"A",1.1,NA,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T3a",185000,1,1.2,"None","","stage iiia",33.3464806913,"Primary Tumor",6
"TCGA-G3-A3CG-01A","TCGA-G3-A3CG",0,673,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",0.4,"A",0.9,67,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G2","M0","N0","T1",131000,1.1,1.4,"Micro","","stage i",32.9506802721,"Primary Tumor",1
"TCGA-BC-A3KG-01A","TCGA-BC-A3KG",0,680,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.6,"",0.7,618,"","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","N0","T2",499000,1.1,1.2,"Micro","","stage ii",25.3154542937,"Primary Tumor",0
"TCGA-ES-A2HS-01A","TCGA-ES-A2HS",1,688,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.8,"A",0.6,1,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","NX","T1",119000,1.3,1,"None","","stage i",29.9382716049,"Primary Tumor",1
"TCGA-DD-A73D-01A","TCGA-DD-A73D",0,693,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.5,"A",0.8,4,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G1","MX","NX","T2",214000,12.5,1,"Micro","Hepatitis B Surface Antigen","stage ii",35.2941176471,"Primary Tumor",3
"TCGA-XR-A8TF-01A","TCGA-XR-A8TF",1,693,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,"None",3.9,"A",0.8,39,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G1","MX","NX","T1",194000,1.1,1.2,"None","","stage i",20.6851502395,"Primary Tumor",4
"TCGA-2Y-A9H9-01A","TCGA-2Y-A9H9",0,697,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.7,"A",0.8,12,"","Hepatitis C","Hepatocellular Carcinoma","G2","MX","N0","T1",203000,11,1.3,"","","stage i",27.7742709254,"Primary Tumor",0
"TCGA-MI-A75G-01A","TCGA-MI-A75G",0,698,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",2.3,"B",0.5,6,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G2","M0","N0","T2",160000,NA,1.2,"None","HCV Genotype","stage ii",21.7775533392,"Primary Tumor",2
"TCGA-G3-A5SJ-01A","TCGA-G3-A5SJ",0,698,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",4.1,"B",1.3,3,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G2","M0","NX","T1",136000,1,1.4,"None","","stage i",29.7527444342,"Primary Tumor",4
"TCGA-DD-A73C-01A","TCGA-DD-A73C",0,701,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.9,"A",0.8,3,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","M0","N0","T3a",247000,11.7,1,"None","HBV Core Antibody","stage iiia",19.3821446936,"Primary Tumor",1
"TCGA-ZP-A9CZ-01A","TCGA-ZP-A9CZ",0,706,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.4,"A",NA,8,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G1","MX","NX","T1",NA,11.5,1.2,"None","Hepatitis B Surface Antigen","not reported",26.1751945211,"Primary Tumor",0
"TCGA-BC-A10Y-01A","TCGA-BC-A10Y",1,711,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4,"",1,10575,"","Alcohol consumption","Hepatocellular Carcinoma","G3","MX","NX","T4",239000,1,1.2,"Micro","","not reported",25.1428571429,"Primary Tumor",0
"TCGA-DD-AAEG-01A","TCGA-DD-AAEG",0,719,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,"None",3,"A",0.6,1,"6 - Established Cirrhosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T1",69000,1.3,1.2,"None","","stage i",18.0172064321,"Primary Tumor",4
"TCGA-DD-AAE9-01A","TCGA-DD-AAE9",0,722,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.1,"A",0.9,3,"1,2 - Portal Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",138000,1.1,1.2,"None","","stage i",23.1404958678,"Primary Tumor",2
"TCGA-2Y-A9GS-01A","TCGA-2Y-A9GS",1,724,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",4,"",1.6,74,"","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","NX","T2",168000,9.9,1.3,"","HBV Core Antibody","not reported",35.0556317635,"Primary Tumor",3
"TCGA-DD-A73A-01A","TCGA-DD-A73A",0,728,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.4,"A",1.4,4,"3,4 - Fibrous Speta","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T1",89000,12.8,1,"None","HBV Core Antibody","stage i",33.690051526,"Primary Tumor",3
"TCGA-FV-A2QQ-01A","TCGA-FV-A2QQ",0,729,0,1,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","N0","T1",NA,NA,NA,"None","","stage i",NA,"Primary Tumor",7
"TCGA-G3-A5SK-01A","TCGA-G3-A5SK",0,744,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.3,"A",0.6,NA,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G1","M0","NX","T1",106000,1.1,NA,"","","stage i",23.4585623753,"Primary Tumor",2
"TCGA-MI-A75H-01A","TCGA-MI-A75H",0,747,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.3,"B",NA,11,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","","MX","NX","",138000,1.1,1.2,"Micro","HCV Genotype","not reported",28.0664238698,"Primary Tumor",2
"TCGA-WX-AA46-01A","TCGA-WX-AA46",0,756,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,"None",4.6,"A",1.2,1,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","MX","NX","T2",205000,1,1.2,"Macro","Hepatitis  C Antibody","stage ii",30.8185404339,"Primary Tumor",1
"TCGA-2Y-A9GY-01A","TCGA-2Y-A9GY",1,757,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,"None",4.2,"",0.6,27600,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","MX","NX","T2",207000,9.5,1.3,"","","stage ii",35.4924578527,"Primary Tumor",3
"TCGA-DD-AAED-01A","TCGA-DD-AAED",0,763,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",4,"A",0.5,2405,"1,2 - Portal Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",211000,1.1,1.2,"None","","stage i",25.039918711,"Primary Tumor",2
"TCGA-ZP-A9D2-01A","TCGA-ZP-A9D2",1,765,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",NA,"A",NA,NA,"1,2 - Portal Fibrosis","Hepatitis C","Hepatocellular Carcinoma","G2","MX","NX","T2",NA,NA,NA,"Micro","Hepatitis C Virus RNA","not reported",25.0135208221,"Primary Tumor",1
"TCGA-G3-A5SI-01A","TCGA-G3-A5SI",1,768,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,"Mild",2.8,"A",0.4,9,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G2","M0","N0","T2",145000,1.4,1.4,"None","","stage ii",23.6202879122,"Primary Tumor",1
"TCGA-BC-A10X-01A","TCGA-BC-A10X",1,770,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.6,"",0.7,264,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","N0","T3a",602000,1,1.2,"Micro","","stage iiia",NA,"Primary Tumor",0
"TCGA-G3-A3CH-11A","TCGA-G3-A3CH",0,780,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",0.3,"A",0.9,41,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T3a",142000,1.2,1.4,"None","","stage iiia",23.3556369145,"Solid Tissue Normal",0
"TCGA-ZP-A9CY-01A","TCGA-ZP-A9CY",0,782,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.9,"A",NA,NA,"6 - Established Cirrhosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G1","MX","NX","T1",93000,11,1.2,"None","","not reported",35.9245152355,"Primary Tumor",1
"TCGA-DD-AAEH-01A","TCGA-DD-AAEH",0,784,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,"None",2.9,"A",0.6,NA,"1,2 - Portal Fibrosis","","Hepatocellular Carcinoma","G2","M0","N0","T1",223000,1.1,1.2,"Micro","","stage i",23.3354661448,"Primary Tumor",4
"TCGA-DD-A3A0-01A","TCGA-DD-A3A0",1,785,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.3,"A",2.7,1,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","NX","T1",138000,13.2,1,"None","HBV Core Antibody","stage i",27.7742709254,"Primary Tumor",0
"TCGA-NI-A8LF-01A","TCGA-NI-A8LF",0,799,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",1.2,"",15,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G3","MX","NX","T1",132000,NA,NA,"None","","stage i",35.5664990937,"Primary Tumor",4
"TCGA-DD-A4NG-11A","TCGA-DD-A4NG",1,802,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.5,"A",0.9,3,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","NX","T3a",220000,10.6,1,"Micro","HBV Core Antibody","stage iiia",34.9494348602,"Solid Tissue Normal",0
"TCGA-DD-AAEE-01A","TCGA-DD-AAEE",0,810,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.7,"A",0.9,3,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G4","M0","N0","T1",221000,1,1.2,"None","","stage i",22.65625,"Primary Tumor",2
"TCGA-DD-A4NI-01A","TCGA-DD-A4NI",0,816,1,1,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,"",4.4,"A",1.1,6,"0 - No Fibrosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G2","M0","NX","T2",187000,12.4,1,"None","HBV Core Antibody","stage ii",33.4640346133,"Primary Tumor",6
"TCGA-ED-A4XI-01A","TCGA-ED-A4XI",0,819,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",2.9,"",54,573,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T2",276000,0.9,1.3,"Micro","Hepatitis B Surface Antigen","stage ii",19.0311418685,"Primary Tumor",1
"TCGA-DD-A39W-11A","TCGA-DD-A39W",1,827,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T3",NA,NA,NA,"None","","stage iii",23.6202879122,"Solid Tissue Normal",0
"TCGA-KR-A7K2-01A","TCGA-KR-A7K2",0,829,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.3,"",1.1,14,"","Hepatitis C","Hepatocholangiocarcinoma (Mixed)","G1","M0","N0","T1",178000,1,1.2,"None","HCV Genotype","stage i",28.6688924372,"Primary Tumor",2
"TCGA-BC-A10T-11A","TCGA-BC-A10T",1,837,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3,"",1.2,NA,"1,2 - Portal Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","MX","NX","T4",450000,1.1,NA,"None","","not reported",NA,"Solid Tissue Normal",0
"TCGA-BC-A10U-11A","TCGA-BC-A10U",1,837,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.3,"",0.9,38,"","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","NX","T2",204000,1.1,1.2,"","","not reported",NA,"Solid Tissue Normal",0
"TCGA-UB-A7MA-01A","TCGA-UB-A7MA",0,848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4,"A",0.7,2008,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocholangiocarcinoma (Mixed)","G2","M0","N0","T2b",6e+05,0.9,1,"Micro","HBV Core Antibody","stage ii",31.2213039486,"Primary Tumor",0
"TCGA-2Y-A9GZ-01A","TCGA-2Y-A9GZ",1,848,0,1,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.5,"A",1.1,7,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","NX","T2",318000,9.9,1.3,"","HBV Core Antibody","stage ii",21.7864923747,"Primary Tumor",4
"TCGA-FV-A3I0-11A","TCGA-FV-A3I0",0,848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.4,"",NA,NA,"","No History of Primary Risk Factors","Hepatocholangiocarcinoma (Mixed)","G2","M0","NX","T2",NA,NA,NA,"Micro","","stage ii",NA,"Solid Tissue Normal",0
"TCGA-BC-4073-01B","TCGA-BC-4073",0,849,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",NA,"",1.5,NA,"","Hemochromatosis","Hepatocellular Carcinoma","G3","MX","N0","T3",253000,1,1.2,"Macro","","stage iiia",NA,"Primary Tumor",1
"TCGA-ED-A5KG-01A","TCGA-ED-A5KG",0,854,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",6,"",3.9,3177,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T2",147000,0.9,1.3,"Micro","Hepatitis B Surface Antigen","stage ii",23.828125,"Primary Tumor",1
"TCGA-G3-A25V-01A","TCGA-G3-A25V",0,860,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"None",0.4,"A",0.7,15,"6 - Established Cirrhosis","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T1",139000,1.1,1.4,"None","","stage i",25.737081415,"Primary Tumor",1
"TCGA-GJ-A3OU-01A","TCGA-GJ-A3OU",0,879,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",3.2,"",0.6,8,"","Other","Hepatocellular Carcinoma","G2","MX","NX","T1",178000,1.1,1,"None","Hepatitis  C Antibody","stage i",61.6730610635,"Primary Tumor",1
"TCGA-DD-AADN-01A","TCGA-DD-AADN",0,898,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",3.5,"A",0.8,151367,"","Hepatitis B","Hepatocellular Carcinoma","G4","MX","NX","T1",176000,1.1,1.2,"Micro","","stage i",24.21875,"Primary Tumor",3
"TCGA-XR-A8TG-01A","TCGA-XR-A8TG",0,898,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",4.3,"",0.9,1,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G2","M0","NX","T1",80000,1.1,1.2,"None","","stage i",20.9711720227,"Primary Tumor",3
"TCGA-DD-A4NN-11A","TCGA-DD-A4NN",1,899,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.3,"A",0.9,4223,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T1",307000,8.8,1,"None","","stage i",22.2063306861,"Solid Tissue Normal",0
"TCGA-KR-A7K8-01A","TCGA-KR-A7K8",0,906,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,"None",3.3,"",1.1,154,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","M0","N0","T1",103000,1.3,1.2,"None","","stage i",37.7162629758,"Primary Tumor",2
"TCGA-ED-A459-01A","TCGA-ED-A459",0,910,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,"",5200,"",1.1,267,"","","Hepatocellular Carcinoma","G2","M0","N0","T2",2e+05,0.9,1.2,"Micro","Hepatitis B Surface Antigen","stage ii",18.2867797339,"Primary Tumor",5
"TCGA-DD-A4NH-01A","TCGA-DD-A4NH",0,917,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,"None",4,"A",0.8,92889,"1,2 - Portal Fibrosis","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","N0","T3b",226000,11.8,1,"Macro","Hepatitis B Surface Antigen","stage iiib",32.8613736866,"Primary Tumor",2
"TCGA-XR-A8TE-01A","TCGA-XR-A8TE",0,925,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.9,"",0.4,809,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","MX","N0","T3",206000,1,NA,"None","","stage iiia",17.4449267719,"Primary Tumor",0
"TCGA-DD-A4NJ-01A","TCGA-DD-A4NJ",0,928,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,"Mild",4.7,"A",0.7,5,"1,2 - Portal Fibrosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G2","M0","N0","T2",303000,11.5,1,"None","HBV Core Antibody","stage ii",32.7186198691,"Primary Tumor",2
"TCGA-DD-A3A9-01A","TCGA-DD-A3A9",1,931,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4,"A",0.9,19930,"0 - No Fibrosis","Other","Hepatocellular Carcinoma","G2","M1","N0","T4",317000,9.3,1,"None","","stage ivb",21.9671201814,"Primary Tumor",2
"TCGA-G3-A25W-11A","TCGA-G3-A25W",0,935,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",0.4,"A",1.5,6,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T3b",308000,0.9,1.2,"Macro","","stage iiib",19.4734066291,"Solid Tissue Normal",0
"TCGA-DD-A4NF-01A","TCGA-DD-A4NF",0,942,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4,"A",0.9,6,"6 - Established Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G2","M0","N0","T1",97000,12.7,1,"None","HBV Core Antibody","stage i",28.7346720572,"Primary Tumor",1
"TCGA-KR-A7K7-01A","TCGA-KR-A7K7",0,951,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.4,"",0.8,308836,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","M0","N0","T2",130000,1,1.2,"Micro","","stage ii",44.2885487528,"Primary Tumor",1
"TCGA-DD-A4NB-01A","TCGA-DD-A4NB",0,989,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",NA,"",0.8,3,"","No History of Primary Risk Factors","Fibrolamellar Carcinoma","G2","M0","N0","T1",296000,13.9,1,"None","","stage i",20.1607012418,"Primary Tumor",1
"TCGA-DD-A1EJ-01A","TCGA-DD-A1EJ",1,1005,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.5,"B",0.6,18840,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N1","T1",608000,10.2,1,"None","HBV Core Antibody","stage iiic",26.986001012,"Primary Tumor",1
"TCGA-DD-A4NA-01A","TCGA-DD-A4NA",0,1008,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",NA,"",0.8,3,"5 - Nodular Formation and Incomplete Cirrhosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N1","T2",332000,9.6,NA,"","HBV Surface Antibody","stage iiic",33.7494556539,"Primary Tumor",0
"TCGA-XR-A8TD-01A","TCGA-XR-A8TD",0,1030,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.8,"A",0.5,188,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T3",334000,1.1,1.2,"None","","stage iiib",28.3530571992,"Primary Tumor",2
"TCGA-DD-AADK-01A","TCGA-DD-AADK",0,1049,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.4,"A",1.2,236,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T2",197000,1,1.2,"Micro","","stage ii",22.6666666667,"Primary Tumor",0
"TCGA-DD-AADJ-01A","TCGA-DD-AADJ",0,1066,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.2,"A",0.6,708,"","","Hepatocellular Carcinoma","G3","M0","N0","T1",203000,1,1.2,"None","","stage i",24.8777196829,"Primary Tumor",2
"TCGA-DD-AAEK-01A","TCGA-DD-AAEK",0,1067,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.1,"A",0.7,5166,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T2",202000,1,1.2,"None","","stage ii",22.4081789853,"Primary Tumor",2
"TCGA-DD-AADI-01A","TCGA-DD-AADI",0,1085,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"",3.8,"A",0.8,27,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",141000,1.1,1.2,"None","","stage i",23.507805326,"Primary Tumor",6
"TCGA-DD-A73F-01A","TCGA-DD-A73F",0,1085,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"None",4.6,"A",1,283,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","M0","N0","T1",243000,10.9,1,"None","","stage i",25.6543723974,"Primary Tumor",2
"TCGA-ZP-A9CV-01A","TCGA-ZP-A9CV",1,1088,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,1,0,0,0,0,0,0,"Severe",4,"A",0.8,48,"","Hepatitis C","Hepatocellular Carcinoma","G1","MX","NX","T1",114000,NA,1,"None","","not reported",19.7133215276,"Primary Tumor",6
"TCGA-ZP-A9D0-01A","TCGA-ZP-A9D0",0,1091,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,"Mild",4.1,"A",0.9,NA,"0 - No Fibrosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G1","MX","NX","T1",185000,11,1.2,"None","","not reported",28.650137741,"Primary Tumor",1
"TCGA-RG-A7D4-01A","TCGA-RG-A7D4",0,1098,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,"",3,"A",1,5650,"","Hepatitis C","Hepatocellular Carcinoma","G2","M0","N0","T2",175000,1,2,"","Hepatitis  C Antibody","stage ii",29.4077879935,"Primary Tumor",5
"TCGA-BD-A3ER-01A","TCGA-BD-A3ER",0,1115,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,"Mild",3.9,"A",0.9,5,"6 - Established Cirrhosis","Hemochromatosis","Hepatocellular Carcinoma","G2","MX","NX","T2",208000,1.2,1.5,"None","HBV Core Antibody","stage ii",31.4056133997,"Primary Tumor",1
"TCGA-BC-A10Q-01A","TCGA-BC-A10Q",1,1135,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.1,"",0.6,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","","MX","NX","T2",287000,0.9,NA,"None","","not reported",NA,"Primary Tumor",3
"TCGA-DD-AADG-01A","TCGA-DD-AADG",0,1145,0,1,0,1,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.2,"A",1,2256,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T3a",170000,1,1.2,"None","","stage iiia",23.828125,"Primary Tumor",6
"TCGA-HP-A5N0-01A","TCGA-HP-A5N0",1,1147,1,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"None",2.6,"",0.5,NA,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","","M0","NX","TX",NA,1.2,NA,"","","not reported",26.7094017094,"Primary Tumor",5
"TCGA-DD-A114-01A","TCGA-DD-A114",1,1149,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,1,0,1,0,0,0,"Mild",3.5,"A",1.2,21,"5 - Nodular Formation and Incomplete Cirrhosis","Hepatitis C","Hepatocellular Carcinoma","G3","M0","","T2",185000,1,1,"Micro","HBV Core Antibody","stage ii",24.7251829329,"Primary Tumor",4
"TCGA-2Y-A9H7-01A","TCGA-2Y-A9H7",0,1168,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.4,"A",1.2,6,"3,4 - Fibrous Speta","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","N0","T1",165000,10.8,1.3,"None","HBV Core Antibody","stage i",42.1923810297,"Primary Tumor",1
"TCGA-DD-AADE-01A","TCGA-DD-AADE",0,1202,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.9,"A",1.1,7,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G4","M0","N0","T1",148000,1.1,1.2,"Micro","","stage i",22.8625344753,"Primary Tumor",2
"TCGA-DD-A4NK-01A","TCGA-DD-A4NK",1,1210,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.1,"A",1.1,3,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T3",372000,8.7,1,"None","Hepatitis B Surface Antigen","stage iiia",NA,"Primary Tumor",2
"TCGA-DD-AAD8-01A","TCGA-DD-AAD8",0,1219,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",4.3,"A",0.6,4,"1,2 - Portal Fibrosis","Hepatitis C","Hepatocellular Carcinoma","G2","M0","N0","T1",130000,1.1,1.2,"None","","stage i",24.6710526316,"Primary Tumor",3
"TCGA-2Y-A9H1-01A","TCGA-2Y-A9H1",1,1229,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.4,"",0.9,3,"1,2 - Portal Fibrosis","Hepatitis C","Hepatocellular Carcinoma","G2","MX","NX","T1",213000,10,1.3,"","Hepatitis  C Antibody","stage i",30.4367155706,"Primary Tumor",1
"TCGA-DD-AADD-01A","TCGA-DD-AADD",0,1231,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",4.1,"A",0.9,9804,"","Hepatitis B","Hepatocellular Carcinoma","G4","M0","N0","T1",299000,1.1,1.2,"None","","stage i",24.0929705215,"Primary Tumor",3
"TCGA-DD-AADA-01A","TCGA-DD-AADA",0,1233,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.1,"A",0.6,8698,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",173000,1.1,1.2,"Macro","","stage i",27.3034383822,"Primary Tumor",1
"TCGA-ZS-A9CE-01A","TCGA-ZS-A9CE",0,1241,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"None",44,"A",78,NA,"0 - No Fibrosis","","Hepatocellular Carcinoma","G1","MX","NX","T2",310000,36.4,15,"Micro","Hepatitis B Surface Antigen","stage ii",NA,"Primary Tumor",2
"TCGA-DD-AADB-01A","TCGA-DD-AADB",0,1242,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",4.5,"A",0.8,419,"","Hepatitis B","Hepatocellular Carcinoma","G4","M0","N0","T1",180000,1,1.2,"None","","stage i",24.9770431589,"Primary Tumor",2
"TCGA-2Y-A9GW-01A","TCGA-2Y-A9GW",1,1271,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.5,"",1,2,"","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","N0","T1",175000,9.7,1.3,"","","stage i",41.9635309745,"Primary Tumor",1
"TCGA-DD-AAD3-01A","TCGA-DD-AAD3",0,1295,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",3.9,"A",0.8,NA,"1,2 - Portal Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",181000,1,1.2,"None","","stage i",24.3024870597,"Primary Tumor",2
"TCGA-DD-AACN-01A","TCGA-DD-AACN",0,1302,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.9,"A",1.5,699,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",185000,1,1.2,"None","","stage i",23.9389897746,"Primary Tumor",2
"TCGA-XR-A8TC-01A","TCGA-XR-A8TC",0,1339,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.9,"A",0.7,47,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","MX","NX","T1",318000,1,1.2,"None","","stage i",21.6441207076,"Primary Tumor",2
"TCGA-DD-AAD5-01A","TCGA-DD-AAD5",0,1345,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,"Mild",3.7,"A",0.6,73,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",349000,1.2,1.2,"None","","stage i",24.2214532872,"Primary Tumor",4
"TCGA-BC-A216-11A","TCGA-BC-A216",0,1351,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.4,"",0.9,831,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","NX","T3",211000,1.4,1.5,"None","","stage iiia",56.1421772754,"Solid Tissue Normal",0
"TCGA-BD-A2L6-11A","TCGA-BD-A2L6",0,1363,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.7,"A",1.2,53,"3,4 - Fibrous Speta","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","NX","T2",222000,1,1.5,"Micro","HBV Core Antibody","not reported",38.9739229025,"Solid Tissue Normal",0
"TCGA-DD-A1EG-11A","TCGA-DD-A1EG",1,1372,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.2,"A",0.6,16,"1,2 - Portal Fibrosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G3","M0","N0","T1",146000,9.1,1,"None","Hepatitis B Surface Antigen","stage i",29.0532879819,"Solid Tissue Normal",0
"TCGA-ZS-A9CD-01A","TCGA-ZS-A9CD",1,1386,0,1,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",48,"A",73,NA,"5 - Nodular Formation and Incomplete Cirrhosis","","Hepatocellular Carcinoma","G2","MX","NX","T2",198000,11.7,17,"None","Hepatitis B Surface Antigen","stage ii",NA,"Primary Tumor",3
"TCGA-BC-A217-01A","TCGA-BC-A217",1,1397,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,"None",4.4,"",0.8,28,"0 - No Fibrosis","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","NX","T2",243000,1,1.2,"Micro","","stage ii",30.4866573827,"Primary Tumor",3
"TCGA-BC-A10S-01A","TCGA-BC-A10S",1,1423,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.6,"",NA,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G1","MX","NX","T3",217000,1.1,NA,"Micro","","not reported",NA,"Primary Tumor",0
"TCGA-DD-AACW-01A","TCGA-DD-AACW",0,1424,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4,"A",1,1726,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",137000,1.1,1.2,"None","","stage i",23.5883292205,"Primary Tumor",2
"TCGA-DD-AACY-01A","TCGA-DD-AACY",0,1450,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,"Mild",3.1,"A",0.6,290,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",114000,1.1,1.2,"None","","stage i",23.6244474928,"Primary Tumor",1
"TCGA-2Y-A9H4-01A","TCGA-2Y-A9H4",0,1452,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",4.6,"A",1.2,11,"","Hepatitis B","Hepatocellular Carcinoma","G2","MX","N0","T1",223000,11,1.3,"None","HBV Core Antibody","stage i",21.872422819,"Primary Tumor",1
"TCGA-BC-4072-01B","TCGA-BC-4072",1,1490,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.4,"",1,NA,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T3",268000,1,1.2,"Macro","","stage iiia",NA,"Primary Tumor",0
"TCGA-DD-A1EH-01A","TCGA-DD-A1EH",0,1495,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,"None",4.7,"B",1,94340,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T3",212000,10.4,1,"Macro","HBV DNA","stage iii",21.8470085203,"Primary Tumor",4
"TCGA-2Y-A9H3-01A","TCGA-2Y-A9H3",0,1516,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",5.3,"",0.9,5640,"1,2 - Portal Fibrosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G1","MX","NX","T2",245000,10.5,1.3,"Micro","HBV Core Antibody","stage ii",32.7705127805,"Primary Tumor",1
"TCGA-DD-AACV-01A","TCGA-DD-AACV",0,1531,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",4.3,"A",1.2,9,"","Alcohol consumption","Hepatocellular Carcinoma","G3","M0","N0","T1",164000,1,1.2,"Micro","","stage i",24.5089457652,"Primary Tumor",1
"TCGA-DD-AAEI-01A","TCGA-DD-AAEI",0,1531,0,0,0,1,0,0,1,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,1,0,1,0,0,0,0,0,"None",3.6,"A",0.9,24,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",161000,1.1,1.2,"None","","stage i",28.6688924372,"Primary Tumor",8
"TCGA-G3-A25T-01A","TCGA-G3-A25T",0,1553,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",0.4,"A",0.7,7,"0 - No Fibrosis","Hepatitis C","Hepatocellular Carcinoma","G2","M0","N0","T3",306000,1.1,1.4,"None","","stage iiia",22.9481157446,"Primary Tumor",0
"TCGA-DD-A11D-01A","TCGA-DD-A11D",1,1560,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.5,"A",1.1,8,"6 - Established Cirrhosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G2","M0","N0","T1",249000,0.9,1,"None","","stage i",27.475629493,"Primary Tumor",3
"TCGA-DD-AACT-01A","TCGA-DD-AACT",0,1562,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,"Mild",4.4,"A",0.7,4,"","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",213000,1,1.2,"None","","stage i",24.8357634994,"Primary Tumor",3
"TCGA-DD-AACU-01A","TCGA-DD-AACU",0,1567,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,"",4.4,"A",1.1,22,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",166000,0.9,1.2,"None","","stage i",24.3141239657,"Primary Tumor",4
"TCGA-DD-AAVX-01A","TCGA-DD-AAVX",0,1570,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",3.9,"A",1,1,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T2",186000,1,1.2,"Micro","","stage ii",20.515086479,"Primary Tumor",2
"TCGA-DD-AACI-01A","TCGA-DD-AACI",0,1618,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.6,"A",1,1,"5 - Nodular Formation and Incomplete Cirrhosis","","Hepatocellular Carcinoma","G3","M0","N0","T2",106000,1,1.2,"None","","stage ii",19.9791883455,"Primary Tumor",3
"TCGA-DD-A116-01A","TCGA-DD-A116",1,1622,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.1,"A",1.1,24,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T3",157000,1,1,"","HBV Core Antibody","stage iiia",23.8367346939,"Primary Tumor",2
"TCGA-2Y-A9GT-01A","TCGA-2Y-A9GT",1,1624,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.7,"C",0.8,17,"","Hepatitis C","Hepatocellular Carcinoma","G2","MX","NX","T1",187000,9.8,1.3,"None","HBV DNA","stage i",36.8313005676,"Primary Tumor",1
"TCGA-DD-AAW3-01A","TCGA-DD-AAW3",0,1633,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,"None",4.1,"",1,3,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T1",241000,NA,1.2,"None","","stage i",24.3865264441,"Primary Tumor",5
"TCGA-G3-A25U-01A","TCGA-G3-A25U",0,1636,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,1,0,0,0,0,0,"Mild",0.3,"A",0.5,10,"0 - No Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",113000,1,1.2,"None","","stage i",20.0777478747,"Primary Tumor",3
"TCGA-DD-AACC-01A","TCGA-DD-AACC",1,1685,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.9,"A",1.3,24,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",208000,1,1.2,"None","","stage i",22.4058769513,"Primary Tumor",2
"TCGA-DD-A39X-01A","TCGA-DD-A39X",1,1694,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.1,"A",0.9,10,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","NX","T1",180000,9.8,1,"None","HBV Surface Antibody","stage i",20.7756232687,"Primary Tumor",1
"TCGA-DD-A4NL-11A","TCGA-DD-A4NL",0,1711,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.4,"",1,2,"0 - No Fibrosis","Other","Hepatocellular Carcinoma","G1","M0","N0","T1",266000,NA,1,"None","HBV Core Antibody","stage i",37.7560225868,"Solid Tissue Normal",0
"TCGA-2Y-A9H2-01A","TCGA-2Y-A9H2",0,1731,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.5,"",1.4,2,"","Alcohol consumption","Hepatocellular Carcinoma","G3","MX","N0","T1",386000,10.8,1.3,"None","HBV Core Antibody","stage i",17.7556818182,"Primary Tumor",0
"TCGA-DD-AACM-01A","TCGA-DD-AACM",0,1769,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.2,"A",1.2,2,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T2",113000,0.9,1.2,"None","","stage ii",21.7051294328,"Primary Tumor",1
"TCGA-G3-A25X-01A","TCGA-G3-A25X",0,1779,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",0.4,"A",0.8,11,"1,2 - Portal Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T2",102000,1,1.4,"None","","stage ii",23.8751147842,"Primary Tumor",0
"TCGA-NI-A4U2-01A","TCGA-NI-A4U2",1,1791,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",NA,"",0.8,5,"1,2 - Portal Fibrosis","Alcohol consumption","Hepatocellular Carcinoma","G1","MX","NX","T3",299000,1,NA,"None","","stage iiia",28.0428165931,"Primary Tumor",2
"TCGA-DD-AACS-01A","TCGA-DD-AACS",0,1804,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,"",4.3,"A",1.1,1,"","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",223000,1,1.2,"None","","stage i",27.041644132,"Primary Tumor",2
"TCGA-DD-AAVS-01A","TCGA-DD-AAVS",0,1823,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3,"A",1,50149,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",281000,1.1,1.2,"None","","stage i",25.2092013585,"Primary Tumor",2
"TCGA-FV-A23B-01A","TCGA-FV-A23B",1,1852,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,"",NA,"",NA,NA,"","Hepatitis C","Hepatocellular Carcinoma","","M0","N0","T2",NA,NA,NA,"","","stage ii",NA,"Primary Tumor",2
"TCGA-DD-AAW2-01A","TCGA-DD-AAW2",0,1855,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4,"A",1.1,3,"6 - Established Cirrhosis","Non-Alcoholic Fatty Liver Disease","Hepatocellular Carcinoma","G2","M0","N0","T1",164000,1,1.2,"None","","stage i",20.5456936226,"Primary Tumor",1
"TCGA-DD-AACO-01A","TCGA-DD-AACO",0,1876,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.7,"A",1.4,5,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",88000,1,1.2,"None","","stage i",15.987507436,"Primary Tumor",3
"TCGA-DD-AAVZ-01A","TCGA-DD-AAVZ",0,1900,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.8,"A",1.2,945,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",98000,1.2,1.2,"None","","stage i",21.203105229,"Primary Tumor",1
"TCGA-2Y-A9GU-01A","TCGA-2Y-A9GU",0,1939,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.4,"",0.9,304,"","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","MX","NX","T1",281000,10.8,1.3,"","HBV Core Antibody","stage i",32.8891887333,"Primary Tumor",0
"TCGA-DD-AAVY-01A","TCGA-DD-AAVY",0,1970,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3,"A",1.2,11,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T3",210000,1,1.2,"Micro","","stage iiia",24.3046178774,"Primary Tumor",2
"TCGA-DD-AAW1-01A","TCGA-DD-AAW1",0,1989,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",4,"A",1.2,4,"6 - Established Cirrhosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T3",126000,1,1.2,"Micro","","stage iiia",21.5138585105,"Primary Tumor",2
"TCGA-DD-AAW0-01A","TCGA-DD-AAW0",0,2015,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.6,"A",1.3,3,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",183000,1,1.2,"None","","stage i",25.3515413737,"Primary Tumor",1
"TCGA-DD-A1EB-01A","TCGA-DD-A1EB",0,2017,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,"None",3.7,"B",1.3,7,"0 - No Fibrosis","Other","Hepatocellular Carcinoma","G2","M0","N0","T1",204000,8.7,1,"None","HBV Core Antibody","stage i",21.1927424152,"Primary Tumor",3
"TCGA-DD-AADR-01A","TCGA-DD-AADR",0,2028,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,"Mild",4.4,"A",1,3,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",75000,1.1,1.2,"None","","stage i",25.9515570934,"Primary Tumor",5
"TCGA-DD-AACJ-01A","TCGA-DD-AACJ",0,2102,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.6,"A",1,25,"","","Hepatocellular Carcinoma","G2","M0","N0","T2",213000,0.8,1.2,"Micro","","stage ii",28.8754400538,"Primary Tumor",2
"TCGA-BC-A110-01A","TCGA-BC-A110",1,2116,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",3.7,"",3.5,NA,"","Alcohol consumption","Hepatocellular Carcinoma","G1","MX","NX","T1",288000,0.9,1.2,"None","","not reported",37.8772112383,"Primary Tumor",0
"TCGA-DD-A3A2-01A","TCGA-DD-A3A2",1,2131,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.2,"A",0.8,NA,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G1","M0","N0","T1",326000,8.8,1.1,"None","","stage i",26.8274207802,"Primary Tumor",2
"TCGA-DD-AACE-01A","TCGA-DD-AACE",0,2184,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",4.4,"A",1.2,2,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",175000,0.9,1.2,"None","","stage i",23.6244474928,"Primary Tumor",2
"TCGA-DD-AAVU-01A","TCGA-DD-AAVU",0,2202,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.6,"A",1.2,2,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T2",166000,1,1.2,"Micro","","stage ii",34.375,"Primary Tumor",2
"TCGA-DD-A4NO-11A","TCGA-DD-A4NO",0,2245,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",4.5,"A",1.6,3,"0 - No Fibrosis","Other","Hepatocellular Carcinoma","G1","M0","N0","T1",201000,9.9,1,"None","HBV Core Antibody","stage i",35.1885330579,"Solid Tissue Normal",0
"TCGA-DD-A1ED-11A","TCGA-DD-A1ED",0,2301,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.2,"A",1.3,3,"0 - No Fibrosis","Alcohol consumption","Hepatocellular Carcinoma","G1","M0","N0","T1",219000,8.9,1,"None","HBV Core Antibody","stage i",30.1162131519,"Solid Tissue Normal",0
"TCGA-DD-AACA-01A","TCGA-DD-AACA",0,2301,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.7,"A",1.2,7,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",136000,0.9,1.2,"None","","stage i",25.7116620753,"Primary Tumor",1
"TCGA-DD-AAVW-01A","TCGA-DD-AAVW",0,2317,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.6,"A",1.1,927,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",212000,1,1.2,"None","","stage i",23.6244474928,"Primary Tumor",0
"TCGA-DD-AACB-01A","TCGA-DD-AACB",0,2324,0,0,0,1,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,"Mild",4.1,"A",1.1,1902,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T1",179000,0.8,1.2,"Micro","","stage i",29.5857988166,"Primary Tumor",6
"TCGA-DD-A4NV-11A","TCGA-DD-A4NV",0,2398,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.9,"A",0.8,3,"0 - No Fibrosis","Other","Hepatocellular Carcinoma","G1","M0","N0","T3",240000,9,1,"None","HBV Core Antibody","stage iiia",40.2609157018,"Solid Tissue Normal",0
"TCGA-ZS-A9CF-02A","TCGA-ZS-A9CF",0,2412,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",51,"",89,NA,"0 - No Fibrosis","Hemochromatosis","Hepatocellular Carcinoma","G2","MX","NX","T2",259000,10.2,17,"Micro","Hepatitis B Surface Antigen","stage ii",NA,"Recurrent Tumor",0
"TCGA-DD-A1EA-01A","TCGA-DD-A1EA",0,2415,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Mild",3.3,"A",1.2,3,"1,2 - Portal Fibrosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T2",209000,10.2,1,"Micro","HBV DNA","stage ii",33.3049886621,"Primary Tumor",2
"TCGA-DD-A113-11A","TCGA-DD-A113",0,2425,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.3,"A",0.8,133,"0 - No Fibrosis","Other","Hepatocellular Carcinoma","G3","M0","N0","T2",365000,0.9,1,"Micro","HBV Core Antibody","stage ii",23.6127508855,"Solid Tissue Normal",0
"TCGA-2Y-A9GX-01A","TCGA-2Y-A9GX",0,2442,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.3,"",0.7,1,"","Alcohol consumption","Hepatocellular Carcinoma","G2","MX","NX","T1",155000,10.3,1.3,"","HBV Core Antibody","stage i",33.9591836735,"Primary Tumor",2
"TCGA-DD-AAVV-01A","TCGA-DD-AAVV",0,2455,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"Mild",4.6,"A",1.3,7,"3,4 - Fibrous Speta","Hepatitis B","Hepatocellular Carcinoma","G3","M0","N0","T2",244000,1.1,1.2,"Micro","","stage ii",28.4409549752,"Primary Tumor",3
"TCGA-DD-A4NS-01A","TCGA-DD-A4NS",1,2456,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",NA,"",1.1,2,"0 - No Fibrosis","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T1",270000,8.8,1,"None","HBV Core Antibody","stage i",20.7967298935,"Primary Tumor",1
"TCGA-FV-A4ZP-01A","TCGA-FV-A4ZP",1,2486,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"",NA,"",NA,20326,"","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","NX","T3",NA,NA,NA,"Micro","","stage iiia",24.4472789116,"Primary Tumor",1
"TCGA-DD-AAVR-01A","TCGA-DD-AAVR",0,2513,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.6,"A",1.1,36,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",174000,1,1.2,"None","","stage i",25.3443526171,"Primary Tumor",1
"TCGA-2Y-A9GV-01A","TCGA-2Y-A9GV",1,2532,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"",4.2,"",0.6,6,"","Alcohol consumption","Hepatocellular Carcinoma","G1","MX","NX","T1",370000,9.5,1.3,"","HBV Core Antibody","stage i",30.4779662232,"Primary Tumor",0
"TCGA-DD-A115-01A","TCGA-DD-A115",1,2542,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,"None",4.1,"A",1.1,10,"0 - No Fibrosis","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T3",337000,1,1,"None","HBV Core Antibody","stage iiia",27.9903628118,"Primary Tumor",2
"TCGA-DD-AAVQ-01A","TCGA-DD-AAVQ",0,2728,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",3,"A",1.1,1456,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G2","M0","N0","T1",128000,1.2,1.2,"None","","stage i",24.622960911,"Primary Tumor",2
"TCGA-DD-A4ND-11A","TCGA-DD-A4ND",0,2746,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.9,"A",0.7,NA,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T1",NA,8.8,1,"None","","stage i",33.9125133364,"Solid Tissue Normal",0
"TCGA-DD-AAVP-01A","TCGA-DD-AAVP",0,2752,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",4.3,"A",1.2,2,"6 - Established Cirrhosis","Hepatitis B","Hepatocellular Carcinoma","G1","M0","N0","T1",189000,1,1.2,"None","","stage i",22.2309871275,"Primary Tumor",3
"TCGA-DD-A1E9-01A","TCGA-DD-A1E9",1,2759,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"Severe",4.1,"A",0.9,202,"6 - Established Cirrhosis","Alcohol consumption","Hepatocellular Carcinoma","G2","M0","N0","T1",110000,10.4,1,"None","HBV Core Antibody","stage i",34.1400757166,"Primary Tumor",1
"TCGA-DD-A3A5-11A","TCGA-DD-A3A5",1,3125,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.2,"A",0.7,55,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T3",312000,8.7,1.1,"None","","stage iii",20.0692041522,"Solid Tissue Normal",0
"TCGA-DD-A3A6-11A","TCGA-DD-A3A6",1,3258,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",4.3,"A",1,NA,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G2","M0","N0","T2",4000,9.3,1.1,"Micro","HBV Core Antibody","stage ii",16.9795918367,"Solid Tissue Normal",0
"TCGA-DD-A4NP-01A","TCGA-DD-A4NP",0,3308,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,"None",2.4,"B",1.9,2,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T1",348000,8.9,1,"None","HBV Core Antibody","stage i",25.2162533116,"Primary Tumor",3
"TCGA-DD-A118-11A","TCGA-DD-A118",0,3437,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.4,"A",0.9,85150,"0 - No Fibrosis","","Hepatocellular Carcinoma","G2","M0","N0","T2",381000,1,1,"None","HBV Core Antibody","stage ii",26.2595847484,"Solid Tissue Normal",0
"TCGA-DD-A73G-01A","TCGA-DD-A73G",0,3478,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",3.2,"A",0.7,2035400,"0 - No Fibrosis","No History of Primary Risk Factors","Hepatocellular Carcinoma","G3","M0","N0","T1",460000,11.7,1,"None","HBV Core Antibody","stage i",18.3142559834,"Primary Tumor",1
"TCGA-2Y-A9H0-01A","TCGA-2Y-A9H0",0,3675,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"None",2,"",0.8,7598,"","Hepatitis C","Hepatocellular Carcinoma","G1","M0","N0","T3",207000,12.2,1.3,"","","stage iiia",27.4691358025,"Primary Tumor",1
